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Tada! The current issue of the Korean Journal of Hema-
tology includes a very impressive, surprising report describ-
ing, for the first time, the statistics of hematologic mali-
gnancies in Korea [1]. In fact, until now, no reliable 
nationwide cancer statistics describing hematologic malig-
nancies have been published in Korea. While the report 
presented in this current issue may be somewhat incomplete, 
it represents an excellent database that can be used both 
domestically and worldwide as an important source of cancer 
statistics from Korea. Because the database contains all 
aspects of population-based, disease-specific statistics, along 
with survival- and death-related data from 1993 to 2008, 
we can analyze and compare our own data with that of 
other countries, allowing high-ranked public officials to 
shape national policies and health strategies in the field 
of hematologic malignancy in the future. 
On the other hand, this statistics presented in the current 
issue could be representative of the estimated incidence 
and prevalence since we still do not have a reporting system 
that enables accurate data collection and creation of a 
nationwide database for specific regions or specific periods 
of time. The data from 1993 and prior should differ quite 
dramatically from data for 2008. However, we recognize 
that the publication of this statistical report provides us 
with a beginning from which we can establish a reliable 
health reporting system in Korea. Undoubtedly, this is the 
first step toward developing more complementary and 
up-to-date health statistics in this country.
Based on an annually increasing trend, we can say for 
certain that greater than 8,000 new cases of blood cancer 
patients were diagnosed in 2008 according to data from 
the Korea National Cancer Incidence Database (KNCIDB) 
[1, 2]. In addition, survival and mortality data from 1993 
to 2008 were obtained from the Korea National Statistics 
Office (KNSO) [1, 2]. These data were combined, and the 
current report calculated, for the first time in Korea, the 
incidence, mortality, prevalence, limited-duration prevalen-
ce, and changes in the annual age-standardized cancer 
incidence rates. Now, Korean medical students can be taught 
oncology using Korea’s own statistics, rather than the stati-
stics of other countries. Therefore, although it is somewhat 
shameful to admit that this is the first publication of national 
data on hematologic malignancies, we should consider this 
a memorable and historical achievement.
To establish further reliable statistics on hematologic 
malignancies, we anticipate that more aggressive efforts will 
be made to collect data from e v e r y  r e g io n a l  d a t a b a s e  in  
Korea. Based on a recent report published in the Journal 
Cancer Research and Treatment in 2011 [2], we found that 
2,561 new cases of leukemia were diagnosed in Korea in 
2008. In contrast to this report, the most recent report 
published in our journal showed that 2,262 new cases of 
lymphoid and myeloid leukemia occurred during the same 
year, according to the same investigators. Moreover, the 
annual increase in incidence was relatively small (1.2-1.4% 
for leukemia compared with 3.9% for other hematologic 
malignancies). An international comparison of the age-stan-
dardized incidence rates of hematologic malignancies also Korean J Hematol 2012;47:1-2.
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revealed that this increase was only about one-half of the 
increase that occurred in USA and Canada. It may be 
incomparable to other western countries. This data con-
tradiction must be resolved in near future. The National 
Cancer Institute’s Surveillance, Epidemiology and End 
Results Program (SEER), published online by SEER Review 
Facts annually [3], may be a paradigm of cancer statistics 
observation and reporting that should be considered. The 
data system used in th e SE ER pro gram is mu ch  more friend ly 
to policy makers, researchers, and even clinicians and 
patients and introduces some new approaches in the field 
of hematologic malignancies, including somewhat brief 
guidelines for chemotherapy, radiation, stem cell transplan-
tation, etc. Furthermore, we could investigate psychosocial 
sequelae, aspects of socioeconomic understanding in the 
context of quality of life issues, and different aspects of 
acute and chronic leukemias in adults and children from 
these SEER reports. A review of the SEER program suggests 
that we still need to better subdivide and define age-specific 
incidence rates for each blood cancer. With regard to 
preventive medicine, it will be helpful for us to study these 
diseases, if the data include epidemiology, as shown in SEER 
approaches.
Notwithstanding the above mentioned insufficiencies of 
our first national blood cancer statistics, we are excited 
to acknowledge the efforts made by many clinicians and 
researchers in establishing this first official report in Korea. 
We will develop many more constructive health policies 
in this field thanks to the framework published today, and 
we should be proud of ourselves for establishing this base 
source for investigating important epidemiologic character-
istics, evaluating progress in disease management, and esta-
blishing future strategies for all hematologic malignancies. 
In the era of aging in Korea, cancer incidence is on the 
rise, and continuous efforts must be made to create more 
efficient cancer control programs and to make data available, 
with significant attention to detail and exquisite skills in 
the periodic statistical analysis of hematologic malignancies. 
W e  h a v e  j u s t  s c r a tched the surface in the proficient 
development of our own cancer control programs.
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